Multiple Sclerosis is the most common immune-mediated inflammatory demyelinating disease of the central nervous system. Educational gaps involving early symptom identification and diagnosis, misdiagnosis, current concepts of neurologic reserve and benefits of early treatment, a rapidly evolving treatment landscape, and increasing goals of therapy create real-world challenges for HCPs that threaten the long-term prognosis of individuals living with MS.
Lucas Kipp, MD
Dr. Kipp specializes in the diagnosis and treatment of neuroimmunological disorders, particularly demyelinating conditions such as multiple sclerosis and neuromyelitis optica. He is interested in translational research connecting expert MS clinicians, world-renown immunology laboratories, and advanced neuroimaging techniques to identify biomarkers of disease and treatment response.
Have you encountered a patient with Multiple Sclerosis? This disease affects 2.8 million people worldwide, with a disproportionate number in the United States. Listen to recent research that has increased understanding of the connection between Epstein-Barr Virus and Multiple Sclerosis. Topics discussed include the basics of Multiple Sclerosis genetic predisposition, risk factors, potential triggers, and ways to modify behavior and diet to reduce disease progression.
How is Multiple Sclerosis accurately diagnosed? This second lecture in the Multiple Sclerosis Series explores how to use a 4 step process to confirm if a patient has MS. Listen and examine 2 case studies and learn common barriers to a correct diagnosis. Learn why there are consequences to misdiagnosing MS in patients. This activity will appeal to all healthcare providers that want expert instruction about the diagnostic criteria, best practices in examination, careful interpretation of MRI scans, and common mistakes to avoid.
What are the early treatment possibilities for Multiple Sclerosis? In the third lecture of the MS Lecture Series, learn about MS phenotypes, the importance of early intervention, and maximizing neurological reserve in patients. Treatments for Multiple Sclerosis continue to evolve, so watch this video to learn the latest concepts and best practices for treating MS patients quickly after diagnosis.
How can providers best provide timely treatment to Multiple Sclerosis patients? Watch the fourth lecture in the MS Series to learn about how to choose disease-modifying treatment options, the importance of monitoring patients at regular intervals to evaluate signs of disease activity, and how to balance patients' risks and comorbidities with the advantages of treatments. Listen in to examine the available data about treating with the escalation approach or early induction approach.
Jeffrey Edward Dunn, MD
Emmanuelle Waubant, MD
Lawrence Steinman, MD
This educational activity is supported in part by an educational grant from Novartis Pharmaceuticals Corporation.